ELMD
AMEXElectromed Inc.
Website
News25/Ratings3
News · 26 weeks18-100%
2025-10-262026-04-19
Mix590d
- Earnings2(40%)
- SEC Filings2(40%)
- Other1(20%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Electromed Inc.SCHEDULE 13G/A - Electromed, Inc. (0001488917) (Subject)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces Record Financial Performance in Fiscal 2026 Second QuarterStrong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2025 ("Q2 FY 2026"). Q2 FY 2026 Company Highlights Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating income increased to a record $3.6 million, a 42.4% increase from the second quarter of the prior fiscal year. Operating margin improve
- PRElectromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 second quarter ended December 31, 2025, on Tuesday, February 10, 2026 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live webcast of the call will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Electrome
- SECElectromed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- INSIDERDirector Tune Kathleen A was granted 3,000 shares, increasing direct ownership by 25% to 15,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Erickson Stan K. was granted 3,000 shares, increasing direct ownership by 8% to 38,817 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Fluet Gregory was granted 3,000 shares, increasing direct ownership by 17% to 21,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Galatowitsch Joseph L. was granted 3,000 shares, increasing direct ownership by 25% to 15,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Skarvan Kathleen was granted 3,000 shares, increasing direct ownership by 9% to 35,622 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Walsh Andrea M. was granted 3,000 shares, increasing direct ownership by 20% to 18,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERDirector Summers Andrew was granted 3,000 shares, increasing direct ownership by 33% to 12,000 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECElectromed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Electromed, Inc. (0001488917) (Filer)
- SECSEC Form 10-Q filed by Electromed Inc.10-Q - Electromed, Inc. (0001488917) (Filer)
- SECElectromed Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces First Quarter Fiscal 2026 ResultsStrong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2025 ("Q1 FY 2026"). Q1 FY 2026 Company Highlights Net revenues increased 15.1% to $16.9 million in Q1 FY 2026, from $14.7 million in the first quarter of the prior fiscal year. Operating income increased to $2.7 million, a 37.8% increase from the first quarter of the prior fiscal year. Net income was $2.1 million, or $0.25 per diluted share, representing an increase of 44.9%, compared to
- PRElectromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing (844) 826-3033 (Domestic) or (412) 317-5185 (International). The live conference call webcast will be accessible in the Investor Relations section of Electromed's website and directly via the following link: Ele
- SECSEC Form DEF 14A filed by Electromed Inc.DEF 14A - Electromed, Inc. (0001488917) (Filer)
- SECSEC Form DEFA14A filed by Electromed Inc.DEFA14A - Electromed, Inc. (0001488917) (Filer)
- INSIDERDirector Summers Andrew sold $1,598,454 worth of shares (65,714 units at $24.32) (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- SECElectromed Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Electromed, Inc. (0001488917) (Filer)
- PRElectromed, Inc. Announces Share Repurchase AuthorizationElectromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed to repurchase up to $10.0 million of Electromed common stock. This follows the exhaustion of Electromed's most recent share repurchase authorization in the fourth quarter of fiscal 2025, as previously reported. The timing and amount of share repurchases, if any, will be determined by management based on its evaluation of market conditions and other considerations. Repurchases may be made from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades
- INSIDERCEO and President Cunniff James L. covered exercise/tax liability with 1,291 shares and was granted 17,000 shares, increasing direct ownership by 12% to 147,751 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)
- INSIDERChief Financial Officer Nagel Bradley M. covered exercise/tax liability with 562 shares and was granted 5,300 shares, increasing direct ownership by 28% to 21,838 units (SEC Form 4)4 - Electromed, Inc. (0001488917) (Issuer)